Are National Perox. latest results good or bad?

Nov 04 2025 07:50 PM IST
share
Share Via
National Peroxide's latest results are concerning, showing a 56.18% decline in net profit and ongoing revenue contraction, with operating margins significantly compressed. The company's financial struggles raise doubts about its sustainability and growth potential.
National Peroxide's latest financial results for Q2 FY26 reveal significant operational challenges. The company reported a net profit of ₹0.39 crores, which reflects a substantial decline of 56.18% compared to the previous quarter and a 42.65% decrease year-on-year. This decline in profitability raises concerns about the company's ability to sustain its operations effectively.
Revenue for the same quarter was ₹68.29 crores, showing a modest sequential growth of 2.45% from ₹66.66 crores in Q1 FY26. However, this figure is still 11.33% lower than the ₹77.02 crores reported in the corresponding quarter of the previous year, indicating a continuing trend of revenue contraction over the years, with a five-year compound annual decline of 12.60%. Operating margins have also come under pressure, standing at 6.59%, down from 13.81% in Q2 FY24, which signifies a significant erosion of over 720 basis points year-on-year. The profit before tax for Q2 FY26 was ₹0.63 crores, down 53.68% from the previous quarter, further highlighting the company's struggle to maintain profitability. In the first half of FY26, National Peroxide's combined net profit amounted to ₹1.28 crores on revenues of ₹134.95 crores, representing a dramatic decline of 77.78% in profitability compared to the first half of FY25. This raises fundamental questions about the sustainability of the company's business model in the current market environment. The company has also seen a revision in its evaluation, reflecting the market's reassessment of its prospects following consecutive quarters of weak performance. The absence of institutional participation in its shareholding, with no holdings from foreign institutional investors, mutual funds, or insurance companies, further underscores concerns regarding the company's governance and growth potential. Overall, National Peroxide's financial results indicate a challenging operational landscape, with deteriorating profitability, revenue pressures, and significant margin compression, all of which suggest the need for strategic interventions to address these fundamental issues.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News